Ovid Therapeutics Inc. financial data

Symbol
OVID on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
18 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 574% % -12%
Debt-to-equity 29% % -33%
Return On Equity -24% % 29%
Return On Assets -19% % 22%
Operating Margin -585% % 95%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 131,874,634 shares 85%
Common Stock, Shares, Outstanding 130,184,353 shares 83%
Entity Public Float $22,200,000 USD -52%
Common Stock, Value, Issued $130,000 USD 83%
Weighted Average Number of Shares Outstanding, Basic 70,975,778 shares 0.51%
Weighted Average Number of Shares Outstanding, Diluted 70,975,778 shares 0.51%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $7,252,000 USD 1181%
Research and Development Expense $25,582,000 USD -30%
General and Administrative Expense $24,109,000 USD -6.1%
Operating Income (Loss) $42,439,000 USD 31%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $17,414,000 USD 34%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $17,414,000 USD 34%
Earnings Per Share, Basic -0.46 USD/shares 33%
Earnings Per Share, Diluted -0.46 USD/shares 33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $13,153,000 USD -50%
Cash, Cash Equivalents, and Short-term Investments $90,447,000 USD 70%
Assets, Current $74,368,000 USD 33%
Property, Plant and Equipment, Net $252,000 USD -42%
Operating Lease, Right-of-Use Asset $11,610,000 USD -9.3%
Other Assets, Noncurrent $0 USD -100%
Assets $150,934,000 USD 64%
Accounts Payable, Current $1,956,000 USD -39%
Employee-related Liabilities, Current $3,106,000 USD 5%
Accrued Liabilities, Current $4,899,000 USD -18%
Liabilities, Current $8,288,000 USD -21%
Operating Lease, Liability, Noncurrent $11,986,000 USD -11%
Liabilities $20,274,000 USD -15%
Accumulated Other Comprehensive Income (Loss), Net of Tax $202,000 USD -477%
Retained Earnings (Accumulated Deficit) $321,713,000 USD -5.7%
Stockholders' Equity Attributable to Parent $130,660,000 USD 92%
Liabilities and Equity $150,934,000 USD 64%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,280,000 USD 38%
Net Cash Provided by (Used in) Financing Activities $13,000 USD -94%
Net Cash Provided by (Used in) Investing Activities $5,102,000 USD -75%
Common Stock, Shares Authorized 315,000,000 shares 152%
Common Stock, Shares, Issued 130,184,353 shares 83%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $15,084,000 USD -47%
Deferred Tax Assets, Valuation Allowance $91,094,000 USD 1.8%
Depreciation $200,000 USD -50%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $17,581,000 USD 34%
Lessee, Operating Lease, Liability, to be Paid $16,978,000 USD -12%
Operating Lease, Liability, Current $1,433,000 USD 7.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,316,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,316,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,469,000 USD 6.6%
Deferred Tax Assets, Operating Loss Carryforwards $70,229,000 USD 13%
Preferred Stock, Shares Issued 0 shares -100%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,469,000 USD 0%
Additional Paid in Capital $452,445,000 USD 21%
Preferred Stock, Shares Outstanding 0 shares -100%
Amortization of Intangible Assets $100,000 USD -50%
Depreciation, Depletion and Amortization $141,000 USD 3.7%
Share-based Payment Arrangement, Expense $4,807,000 USD -23%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares 0%